Providing deeper insights, analysts have established 12-month price targets, indicating an average target of $57.33, along ...
Vertex Pharmaceuticals offers promising opportunities in pain management, cystic fibrosis treatments, and a diversified ...
2-Year U.S. Treasury Note Continuous Contract $102.836 0.023 0.02% 5-Year U.S. Treasury Note Continuous Contract $106.477 0.078 0.07% 10-Year U.S. Treasury Note Continuous Contract $109.125 0.156 ...
2-Year U.S. Treasury Note Continuous Contract $102.848 0.035 0.03% 5-Year U.S. Treasury Note Continuous Contract $106.508 0.109 0.10% 10-Year U.S. Treasury Note Continuous Contract $109.172 0.203 ...
DA Davidson analyst William Jellison initiated coverage on Vertex, Inc. VERX with a Buy rating and announced a price target ...
Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world ...
Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback